XML 15 R3.htm IDEA: XBRL DOCUMENT v3.10.0.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
REVENUES $ 663 $ 7,526 $ 7,222 $ 16,773
COST OF REVENUES (1,917) (6,066) (7,024) (13,677)
GROSS PROFIT (LOSS) (1,254) 1,460 198 3,096
RESEARCH AND DEVELOPMENT EXPENSES [1] (10,803) (7,118) (25,565) (22,389)
Less – grants 732 729 1,810 2,545
RESEARCH AND DEVELOPMENT EXPENSES, NET (10,071) (6,389) (23,755) (19,844)
SELLING, GENERAL AND ADMINISTRATIVE EXPENSES [1] (2,638) (2,836) (7,294) (8,187)
OPERATING LOSS (13,963) (7,765) (30,851) (24,935)
FINANCIAL EXPENSES (1,811) (3,680) (5,824) (8,809)
FINANCIAL INCOME 230 8 437 1,670
LOSS FROM CHANGE IN FAIR VALUE OF CONVERTIBLE NOTES EMBEDDED DERIVATIVE       (38,061)
FINANCIAL EXPENSES, NET (1,581) (3,672) (5,387) (45,200)
NET LOSS FOR THE PERIOD $ (15,544) $ (11,437) $ (36,238) $ (70,135)
NET LOSS PER SHARE OF COMMON STOCK BASIC AND DILUTED $ (0.10) $ (0.09) $ (0.25) $ (0.55)
WEIGHTED AVERAGE NUMBER OF SHARES OF COMMON STOCK USED IN COMPUTING LOSS PER SHARE – BASIC AND DILUTED 148,187,513 132,549,001 146,752,355 128,223,722
[1] Includes share-based compensation